327 related articles for article (PubMed ID: 34105142)
21. [Hypereosinophilic syndrome--recent developments in diagnosis and treatment].
Hellmich B; Holl-Ulrich K; Gross WL
Dtsch Med Wochenschr; 2007 Sep; 132(37):1892-6. PubMed ID: 17823882
[TBL] [Abstract][Full Text] [Related]
22. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2022 Jan; 97(1):129-148. PubMed ID: 34533850
[TBL] [Abstract][Full Text] [Related]
23. An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes.
Chen MM; Roufosse F; Wang SA; Verstovsek S; Durrani SR; Rothenberg ME; Pongdee T; Butterfield J; Lax T; Wechsler ME; Stein ML; Ogbogu PU; Kahwash BM; Mathur SK; Simon D; Akuthota P; Holland N; Wetzler L; Ware JM; Guo C; Fay MP; Khoury P; Klion AD; Bochner BS
J Allergy Clin Immunol Pract; 2022 May; 10(5):1217-1228.e3. PubMed ID: 35181548
[TBL] [Abstract][Full Text] [Related]
24. Effect of cyclosporine on lymphocytic variant hypereosinophilic syndrome.
Tabata R; Tabata C; Katashima Y; Yasumizu R
Int Immunopharmacol; 2013 Aug; 16(4):488-91. PubMed ID: 23669338
[TBL] [Abstract][Full Text] [Related]
25. [New insights into hypereosinophilic syndromes].
Bletry O; Kahn JE; Ackermann F; Charles P; Legrand F
Bull Acad Natl Med; 2010 Mar; 194(3):547-59; discussion 559-60. PubMed ID: 21171248
[TBL] [Abstract][Full Text] [Related]
26. Clinical Profile and Treatment in Hypereosinophilic Syndrome Variants: A Pragmatic Review.
Requena G; van den Bosch J; Akuthota P; Kovalszki A; Steinfeld J; Kwon N; Van Dyke MK
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2125-2134. PubMed ID: 35470096
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome.
Kuang FL; Fay MP; Ware J; Wetzler L; Holland-Thomas N; Brown T; Ortega H; Steinfeld J; Khoury P; Klion AD
J Allergy Clin Immunol Pract; 2018; 6(5):1518-1527.e5. PubMed ID: 29751154
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive Review.
Nanagas VC; Kovalszki A
Clin Rev Allergy Immunol; 2019 Oct; 57(2):194-212. PubMed ID: 30003499
[TBL] [Abstract][Full Text] [Related]
29. Biologics and Hypereosinophilic Syndromes: Knowledge Gaps and Controversies.
Kuang FL; Khoury P; Weller PF; Wechsler ME; Klion AD
J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2666-2671. PubMed ID: 37507068
[TBL] [Abstract][Full Text] [Related]
30. Imatinib for the treatment of hypereosinophilic syndromes.
Helbig G
Expert Rev Clin Immunol; 2018 Feb; 14(2):163-170. PubMed ID: 29303368
[TBL] [Abstract][Full Text] [Related]
31. Management of hypereosinophilic syndrome: a prospective study in the era of molecular genetics.
Dahabreh IJ; Giannouli S; Zoi C; Zoi K; Voulgarelis M; Moutsopoulos HM
Medicine (Baltimore); 2007 Nov; 86(6):344-354. PubMed ID: 18004179
[TBL] [Abstract][Full Text] [Related]
32. The hypereosinophilic syndromes: current concepts and treatments.
Gleich GJ; Leiferman KM
Br J Haematol; 2009 May; 145(3):271-85. PubMed ID: 19243381
[TBL] [Abstract][Full Text] [Related]
33. Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate.
Ault P; Cortes J; Koller C; Kaled ES; Kantarjian H
Leuk Res; 2002 Sep; 26(9):881-4. PubMed ID: 12127565
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of hypereosinophilic syndrome with cyclosporine.
Donald CE; Kahn MJ
Am J Med Sci; 2009 Jan; 337(1):65-6. PubMed ID: 19002011
[TBL] [Abstract][Full Text] [Related]
35. [The hypereosinophilic syndrome].
Jegou J; Barete S; Frances C
Ann Dermatol Venereol; 2003; 130(6-7):664-6. PubMed ID: 13679710
[No Abstract] [Full Text] [Related]
36. Hypereosinophilic syndrome: approach to treatment in the era of precision medicine.
Klion A
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):326-331. PubMed ID: 30504328
[TBL] [Abstract][Full Text] [Related]
37. Complete remission of hypereosinophilic syndrome after interferon-alpha therapy: report of a case and literature review.
Yoon TY; Ahn GB; Chang SH
J Dermatol; 2000 Feb; 27(2):110-5. PubMed ID: 10721659
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes.
Dispenza MC; Bochner BS
Curr Hematol Malig Rep; 2018 Jun; 13(3):191-201. PubMed ID: 29680938
[TBL] [Abstract][Full Text] [Related]
39. Hypereosinophilic syndrome and proliferative diseases.
Ionescu MA; Wang L; Janin A
Acta Dermatovenerol Croat; 2009; 17(4):323-30. PubMed ID: 20021987
[TBL] [Abstract][Full Text] [Related]
40. Cough in hypereosinophilic syndrome: case report and literature review.
Xie J; Zhang J; Zhang X; Zhang Q; Chung KF; Wang C; Lai K
BMC Pulm Med; 2020 Apr; 20(1):90. PubMed ID: 32293378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]